Soliton, Inc. (SOLY:NASDAQ) Annual Reports & Investor Relations Material

Overview

Houston-based medical device company Soliton, Inc. uses a proprietary platform technology to create a range of products, with the aim of lowering the cost of tattoo removal and increasing profit for practitioners. Soliton's first product, a tattoo-removal device called Rapid Acoustic Pulse, has been FDA-cleared for use with lasers. Soliton is also investigating the use of RAP technology for other cosmetic treatments, such as cellulite reduction. While the company has completed trials on this application, RAP is not yet approved for this use.

Frequently Asked Questions

What is Soliton, Inc.'s ticker?

Soliton, Inc.'s ticker is SOLY

What exchange is Soliton, Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Soliton, Inc.'s headquarters?

They are based in Houston, Texas

How many employees does Soliton, Inc. have?

There are 1-10 employees working at Soliton, Inc.

What is Soliton, Inc.'s website?

It is https://www.soliton.com/

What type of sector is Soliton, Inc.?

Soliton, Inc. is in the Healthcare sector

What type of industry is Soliton, Inc.?

Soliton, Inc. is in the Medical Appliances & Equipment industry

Who are Soliton, Inc.'s peers and competitors?

The following five companies are Soliton, Inc.'s industry peers:

- ResMed

- Nemaura Medical

- Medtronic

- Medigus Ltd.

- Silk Road Medical